Compare Colgate-Palmolive Company (CL) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Colgate-Palmolive Company vs Smith & Nephew plc — how do they compare? Colgate-Palmolive Company trades at $92.31 (market cap $74.26B), while Smith & Nephew plc trades at $30.05 (market cap $12.50B). The key difference: Colgate-Palmolive Company is far larger — about 5.9× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.64%). Which is the better fit depends on your goals.
| CL | SNN | |
|---|---|---|
Market Cap | $74.26B | $12.50B |
Sector | Consumer Staples | Health |
52-Week High | $99.14 | $38.70 |
52-Week Low | $74.98 | $28.73 |
Enterprise Value | $80.74B | $15.53B |
Dividend Yield | 2.28% | 2.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
